Haleon nabs finance chief from Tate & Lyle as CFO steps down
24th Apr 2024 07:41
(Sharecast News) - The chief financial officer of consumer health company Haleon is to step down after three years and will be replaced by Tate & Lyle's CFO Dawn Allen.
Read moreLondon close: Stocks mixed as Japan ends negative rate policy
19th Mar 2024 16:23
(Sharecast News) - London markets closed with a mixed performance on Tuesday, as investors weighed the implications of Japan's decision to end negative interest rates against upcoming policy announcements from the US Federal Reserve and the Bank of England later in the week.
Read morePfizer sells bigger-than-expected stake in Haleon
19th Mar 2024 09:39
(Sharecast News) - Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.
Read moreLondon close: Stocks slip ahead of central bank decisions
18th Mar 2024 15:33
(Sharecast News) - London markets closed with a slight downturn on Monday as investors monitored upcoming rate decisions from a number of central banks.
Read morePfizer to cut stake in Haleon to 24% from 32%
18th Mar 2024 07:35
(Sharecast News) - Consumer healthcare company Haleon said on Monday that Pfizer plans to sell around 630m shares in the company in a public offering.
Read moreLondon close: Stocks fall as US inflation tops forecasts
14th Mar 2024 16:33
(Sharecast News) - London's equity markets finished in negative territory on Thursday, driven by a flurry of stocks going ex-dividend and investor reactions to the latest US producer inflation and jobless data.
Read moreLondon close: Stocks finish positive as US inflation moderates
29th Feb 2024 16:05
(Sharecast News) - London's stock markets finished with moderate gains on Thursday, buoyed by a combination of factors including a slowdown in US inflation, robust UK earnings reports, and encouraging mortgage approvals figures.
Read moreHaleon sees higher sales in 2024 as FY profits come in flat
29th Feb 2024 07:23
(Sharecast News) - Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.
Read moreHaleon offloads ChapStick brand for $430m
25th Jan 2024 07:14
(Sharecast News) - Consumer health group Haleon, the company behind Sensodyne toothpaste, Panadol and Advil painkillers, has announced it is selling the ChapStick lip balm brand for $430m.
Read moreLondon close: Stocks rise on positive news from China
24th Jan 2024 16:31
(Sharecast News) - London markets finished with a positive performance on Wednesday, driven by gains in the mining sector following China's announcement of an upcoming reduction in the reserve requirement ratio for banks.
Read moreBroker tips: Greggs, Haleon
24th Jan 2024 15:58
(Sharecast News) - Numis initiated coverage of Greggs on Wednesday with a 'hold' rating and 2,560p price target as it said growth was "baked in".
Read moreJPMorgan puts Haleon on negative catalyst watch
24th Jan 2024 12:32
(Sharecast News) - JPMorgan has placed consumer health company Haleon on negative catalyst watch ahead of its annual report next month, saying volume and earnings risks will weigh on the stock's rating.
Read moreGSK raises £978m through Haleon share sale
17th Jan 2024 08:05
(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.
Read moreBofA Merrill Lynch reinstates Haleon at 'buy'
7th Nov 2023 13:58
(Sharecast News) - Bank of America Merrill Lynch reinstated coverage of GSK spinoff Haleon on Tuesday, with a 'buy' rating and 390p price target.
Read moreLondon close: Stocks rise as BoE keeps rates steady
2nd Nov 2023 15:12
(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.
Read more